Capitalization

6 Months Ended

Mar. 31, 2019

Capitalization, Long-term Debt and Equity [Abstract]

Summary of Changes in Common Stock Equity



	Common Stock			Paid In Capital			Earnings Reinvested in the Business			Accumulated Other Comprehensive Income (Loss)
	Shares	Amount		Paid In Capital			Earnings Reinvested in the Business			Accumulated Other Comprehensive Income (Loss)
	(Thousands, except per share amounts)
Balance at January 1, 2019	86,271	$	86,271	$	817,076		$	1,172,334		$	(28,690	)
Net Income Available for Common Stock							90,595
Dividends Declared on Common Stock ($0.425 Per Share)							(36,678		)
Cumulative Effect of Adoption of Authoritative Guidance for Reclassification of Stranded Tax Effects							10,406
Other Comprehensive Loss, Net of Tax										(25,596		)
Share-Based Payment Expense ⁽¹⁾				5,038
Common Stock Issued (Repurchased) Under Stock and Benefit Plans	30	30		(277		)
Balance at March 31, 2019	86,301	$	86,301	$	821,837		$	1,236,657		$	(54,286	)

Balance at October 1, 2018	85,957	$	85,957	$	820,223		$	1,098,900		$	(67,750	)
Net Income Available for Common Stock							193,256
Dividends Declared on Common Stock ($0.85 Per Share)							(73,342		)
Cumulative Effect of Adoption of Authoritative Guidance for Financial Assets and Liabilities							7,437
Cumulative Effect of Adoption of Authoritative Guidance for Reclassification of Stranded Tax Effects							10,406
Other Comprehensive Income, Net of Tax										13,464
Share-Based Payment Expense ⁽¹⁾				9,955
Common Stock Issued (Repurchased) Under Stock and Benefit Plans	344	344		(8,341		)
Balance at March 31, 2019	86,301	$	86,301	$	821,837		$	1,236,657		$	(54,286	)

Balance at January 1, 2018	85,761	$	85,761	$	800,348		$	1,014,733		$	(40,919	)
Net Income Available for Common Stock							91,847
Dividends Declared on Common Stock ($0.415 Per Share)							(35,641		)
Other Comprehensive Loss, Net of Tax										(6,841		)
Share-Based Payment Expense ⁽¹⁾				3,563
Common Stock Issued Under Stock and Benefit Plans	121	121		6,215
Balance at March 31, 2018	85,882	$	85,882	$	810,126		$	1,070,939		$	(47,760	)

Balance at October 1, 2017	85,543	$	85,543	$	796,646		$	851,669		$	(30,123	)
Net Income Available for Common Stock							290,501
Dividends Declared on Common Stock ($0.83 Per Share)							(71,231		)
Other Comprehensive Loss, Net of Tax										(17,637		)
Share-Based Payment Expense ⁽¹⁾				7,074
Common Stock Issued Under Stock and Benefit Plans	339	339		6,406
Balance at March 31, 2018	85,882	$	85,882	$	810,126		$	1,070,939		$	(47,760	)


⁽¹⁾	Paid in Capital includes compensation costs associated with performance shares and/or restricted stock awards. The expense is included within Net Income Available For Common Stock, net of tax benefits.

Common Stock. During the six months ended March 31, 2019, the Company issued 126,879 original issue shares of common stock as a result of SARs exercises, 79,654 original issue shares of common stock for restricted stock units that vested and 281,882 original issue shares of common stock for performance shares that vested. The Company also issued 14,583 original issue shares

of common stock to the non-employee directors of the Company who receive compensation under the Company’s 2009 Non-Employee Director Equity Compensation Plan, as partial consideration for the directors’ services during the six months ended March 31, 2019. Holders of stock-based compensation awards will often tender shares of common stock to the Company for payment of applicable withholding taxes. During the six months ended March 31, 2019, 159,137 shares of common stock were tendered to the Company for such purposes. The Company considers all shares tendered as cancelled shares restored to the status of authorized but unissued shares, in accordance with New Jersey law.

Current Portion of Long-Term Debt. None of the Company's long-term debt as of March 31, 2019 and September 30, 2018 had a maturity date within the following twelve-month period.